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Abstract 
Background: To determine the expression of Ki-67 
in mucoepidermoid carcinoma (MEC) and to 
correlate with histological grades. 
Methods: In this descriptive study, 
histopathological grading of mucoepidermoid 
carcinomas  was done on the basis of grading system 
of  Auclair et al.  Points were assigned on the basis of 
five histopathological features( intracystic 
component, neural invasion, necrosis, mitosis and 
anaplasia).   
After grading of the tumor , immunohistochemical 
marker Ki-67 was applied. For Ki-67 expression, the 
scoring system of  Lyzogubov et al was followed .  
The chi-square test was used to compare histological 
grade with expression of immune marker Ki-67. P 
value   < 0.001 was considered statistically 
significant. 
Results: Out of 30 cases,  majority( 70%) were 
males, with male to female ratio of 1:0.43.The range 
in age of the patient was 17 to 88 years and mean age 
was 44.27 years. Parotid gland was the most common 
site. Thirteen (43%) were low grade cases, 10 (33%) 
were high grade cases and 7 (23%) were intermediate 
grade cases of MEC. The Ki-67 % expression in low 
grade MEC varied between 0-10% with mean 
expression of 2.85%. While the expression in 
intermediate grade was 5-40% with a mean of 25% 
and the Ki-67 % expression in high grade was 30-
75% with a mean of 61.5%.This highlighted 
increasing Ki-67 expression with worsening grade of 
the tumour. 
Conclusions: Expression of Ki-67 is high in high 
grade cases of MEC while it is negative or less 
positive in low grade cases of MEC. Correlation 
between grades of MEC and expression of Ki-67 is 
statistically significant. It can be used as a prognostic 
marker for MEC along with other prognostic and 
clinicopathological parameters. 
Key Words: Mucoepidermoid Carcinoma,Ki-
67,Salivary Glands. 
 
Introduction 
Mucoepidermoid carcinoma (MEC) constitutes almost 
10% of all salivary gland tumours and is one of the 
most common malignant salivary gland neoplasms, 
comprising approximately 35%.1MEC are 
characterized by the presence of mucous cells, 
epidermoid cells and intermediate cells .It varies 
histologically from solid, mainly epidermoid tumours 
to cystic, predominately mucous cell tumours. Grading 
of MEC is based on subjective microscopic evaluation 
of the prevalence of the different cell types as well as 
features of atypia and aggressiveness. 2,3 
Differentiation of MEC in low grade, intermediate 
grade and high grade is at times difficult especially the 
differentiation between intermediate grade and high 
grade and between high grade MEC and poorly 
differentiated squamous cell carcinoma. 
Histopathological grading is an important prognostic 
factor regarding 5-year survival outcome (92-100% in 
low grade, 62-93% in intermediate grade and 0-43% in 
high grade).4 This differentiation as well as prediction 
of prognosis can be facilitated by 
immunohistochemistry. Ki-67 has emerged as a 
marker with a strong potential to forecast and predict 
the behavior of MEC by indicating its proliferative 
capacity.5,6        
Ki-67, also known as MKi67 (monoclonal antibody Ki-
67), is a protein encoded by MKi67 gene in humans. It 
can be easily detected in proliferating cells which helps 
in understanding the rate at which cells within a 
tumour are growing. Expression of Ki-67 in MEC is 
seen in 18-47.7% cases. It is associated with poor 
prognosis, upgradation of histopathological grading 
and more aggressive behaviour of the tumor.7,8,9 
 
Patients  and Methods 
In this descriptive study , performed in Armed Forces 
Institute of Pathology, Rawalpindi  cases of MEC ,from 
 January 2010 to  December 2013 were included . 
Histopathological grading was re-assessed on the  
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samples after viewing them under the microscope. 
Grading was done on the basis of grading system 
described by Auclair et al (Table 1). 2 These points 
were assigned on the basis of five histopathological 
features, which are the intracystic component, neural 
invasion, necrosis, mitosis and anaplasia. Necrosed, 
scanty and autolysed tissue samples were excluded as 
application of the immunohistochemical marker was 
difficult and uncertain in such cases. After grading of 
the tumor samples, immunohistochemical marker Ki-
67 was applied. For    Ki-67 expression, scoring system 
used by Lyzogubov et al, was followed (Table 2).10  
chi-square test was used to compare histological grade 
with expression of immune marker Ki-67. p value < 
0.001 was considered statistically significant. 
 
Table 1:Mucoepidermoid carcinomas- Auclaier 
et al grading system 2 
Category Score 
Low 0-4 
Intermediate 5-6 
High 7-14 
 
Table 2: Ki-67 Scoring system of  
 Lyzogubov et al 10 
Positivity of  cells Score 
<1% 0 
1-20% 1 
21-50% 2 
>50% 3 
 
Results 
The age range of patients was from 17 to 88 years with 
a mean of 44.27 years. Majority were found to be in 
age between 30-60 years (Table 3).Majority (70%) were 
males, with male to female ratio of 1 : 0.43. Twenty 
(73.3%) occurred in the Parotid gland (73.3%) was the 
cpommonest site involved (Table 4). 13 cases were 
Low grade MEC revealed the highest proportion 
(43.3%) (Table 5). 
 
Table3:Age distribution of the cases. 
Age (years) Frequency 
(numbers) 
Proportion (%) 
Below 30 9 30 
30 – 60 16 53.3 
Above 60 5 16.7 
Total 30 100.0 
The Ki-67 % expression in low grade MEC varied 
between 0-10% with mean expression of 2.85%.While  
the expression in intermediate grade was 5-40% with a 
mean of 25% and the Ki-67 % expression in high grade 
was 30-75% with a mean expression of 61.5%. This 
highlighted increasing Ki-67 expression with 
worsening grade of the tumour (Table 6). 
Table 4:Mucoepidermoid carcinoma- Sites 
Site No(%) 
Parotid gland 22 (73.3) 
Hard palate 4(13.3) 
Submandibular gland 3 10.0%) 
Tongue 1(3.3) 
Table 5: Mucoepidermoid carcinoma- Grading 
Grade No(%) 
Low 13 (43.3) 
Intermediate 10 (43.3) 
 High 07 (23.3) 
Table 6: Mucoepidermoid carcinoma- Ki-67 
expression 
 Cases Min Max Mean+SD 
High Grade 
MECs 
10 30 75 61.5+13.954 
Intermediate 
Grade MECs 
7 5 40 25+13.540 
Low Grade 
MECS 
13 0 10 2.846+3.367 
Table 7: Chi-square (Fisher Exact test ) between 
different grades of MECs and expression  
of Ki-67 
Grade of 
MECs 
Value Degree of 
Freedom 
p value 
Low vs 
Intermediate 
25.28 3 <0.001 
Intermediate 
vs High 
26.352 3 <0.001 
High vs Low 26.521 3 ,0.001 
 
Table 8: Expression of Ki-67 in the three grades 
of MECs 
Grade of 
MEC 
0% 1-20 
% 
21-
50% 
>50% Total 
Low Grade 2 11 0 0 13 
Intermediate  0 3 4 0 7 
High Grade  0 0 2 8 10 
Total  2 14 6 8 30 
Chi square test, used to display association between 
the grade of the MECs and the % of the expression of 
Ki-67, found  significant association between the two 
variables with a p <0.001 (Table 7). On cross tabulation 
of different grades of the Mucoepidermoid carcinomas 
with nuclear positivity, it was found that out of 13  
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Table 9 : Expression of Ki-67 as positive or 
negative in the grades of MECs 
Grade of 
MECs 
Ki-67 Total Grade of 
MECs 
 Positive Negative  
Low Grade 11 2 13 
Intermediate 
Grade 
7 0 7 
High Grade 10 0 10 
Total 28 2 30 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Expression of Ki-67 in Low Grade MEC 
with 1-20% staining.(Low Power View (10x100 
magnification)  
 
 
 
 
 
 
 
 
 
 
 
Figure 2 : Expression of Ki-67 in High Grade MEC 
with > 50% staining(Low Power View)  
cases of low grade MECs, there was no nuclear 
staining in 2 cases, 1-20% positive nuclear staining in 
11 cases. None of the cases showed more than 20% 
positive nuclear staining of tumor cells.There were 
total 7 cases of intermediate MECs. There were 3 cases 
with 1-20% positive staining and 4 cases of 21-50% 
positivity of tumor cells with Ki-67.High grade tumors 
cases were 10 in number. None of the cases presented 
with less than 20% positivity of tumor cells with Ki-67. 
High percentage of stained tumor cells (21-50%) was 
seen in 2 cases, whereas 8 cases showed maximum 
value of Ki-67 scoring of >50% (Table 8). 
None of the low grade and intermediate grade MEC 
cases showed Ki-67 staining in more than 50% of the 
neoplastic cells. Eight out of 10 cases (80%) of high 
grade MEC showed Ki-67 staining in 50% or more of 
the neoplastic cells.Only two case of high grade MEC 
(20% of cases) showed Ki-67 staining in less than 50% 
of neoplastic cells. According to the modification made 
in the criteria used for Ki-67 scoring, out of 30 cases of 
tumor, 2 cases were found to be negative and 28 cases 
were positive. In low grade tumors, only 2 cases were 
found to be negative while in intermediate and high 
grade tumors none of the cases were found negative 
(Table 9; Figures 1&2). 
 
Discussion 
Salivary gland neoplasms comprise 1-4%  of all body 
tumours .9 MEC is the commonest of all salivary gland 
malignancies accounting for approximately 10-15% of 
salivary gland tumours . This tumour has been 
observed and documented in major and minor 
salivary glands of both children and adults. It is a 
unique epithelial neoplasm which is composed of 
epidermoid, mucous and intermediate cells. 9-11   MEC 
exhibits a clinical behavior strongly dependent upon 
its histological grade thus varying from a relatively 
low grade neoplasm to an extremely aggressive tumor 
showing high mortality. Studies have proved that 
histological grade of MEC is a predictor of prognosis 
and also affects the treatment protocol for 
patients.2,12,4,11,13  Middle age male people are  more 
commonly affected . 14,15 Most of studies revealed 
parotid as the commonest site. 16-18 
Results of present study  signifies the importance of 
Ki-67 as a proliferative marker . Our findings suggest 
that greater percentage of expression of Ki-67 is 
associated with high proliferative activity, up 
gradation of histopathologic grading and more 
aggressive behavior of the tumor. In 10 of the high 
grade cases Ki-67 showed strong positive results 
implying that high grade tumors show high 
proliferative activity. Conversely, out of 13 cases of 
low grade only 2 cases showed a negative expression. 
The 7 cases of intermediate grade tumors with a 
positive Ki-67 points towards the aggressiveness of 
these tumors and they should be treated like 
aggressive malignant tumors. 
Negativity of Ki-67 points towards a higher survival 
rate.5 Positive expression of Ki-67 points towards an 
unfavorable prognosis. Studies showed that  Ki-67 is a 
significant tumor marker which correlates with high 
recurrence rate and distant metastasis.19 Increased 
expression of Ki-67 (p≤ 0.001) is associated with 
aggressive behavior of tumors and a poor prognosis 
which is in accordance with our results. Positive 
expression of Ki-67 in intermediate grade of MEC is a 
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predictor of poor prognosis. It is emphasized that high 
expression of Ki-67 (p≤ 0.0001) is related to higher 
histological grade and thus its importance as a 
proliferative cell marker has been highlighted.20  
Lazzaro and Cleveland took small oral biopsy 
specimen of both benign and malignant salivary gland 
tumors and conducted a study. 8 They stained the 
samples with Ki-67 antibody. All cases were evaluated 
in terms of staining and percentage of tumor cells. 
Their findings suggested that Ki-67 was expressed in 
low levels in small oral biopsies of both benign and 
malignant salivary gland tumors. The unexpected 
result in this study was even Adenoid cystic 
carcinoma, which is an aggressive tumor, also 
presented low expression of Ki-67. 8 
 
Conclusions 
Expression of Ki-67 is high in high grade cases of  
MEC while it is negative or less positive in low grade 
cases of MEC. Correlation between grades of MEC and 
expression of Ki-67 is statistically significant. It can be 
used as a prognostic marker for MEC along with other 
prognostic and clinicopathological parameters 
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